Innate Pharma (IPHA) Goodwill & Intangibles (2017 - 2024)

Innate Pharma (IPHA) has 8 years of Goodwill & Intangibles data on file, last reported at $128149.6 in Q2 2024.

• For the quarter ending Q2 2024, Goodwill & Intangibles fell 86.97% year-over-year to $128149.6; the trailing twelve-month figure through Jun 2024 stood at $128149.6 (down 86.97% YoY), and the FY2023 full-year result was $447591.0, down 71.81% from the prior year.
• Goodwill & Intangibles for Q2 2024 stood at $128149.6, down from $447591.0 in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $95.2 billion in Q2 2020 and bottomed at $128149.6 in Q2 2024.
• The 5-year median for Goodwill & Intangibles is $46.2 million (2022), against an average of $10.6 billion.
• Peak annual rise in Goodwill & Intangibles reached 8.4% in 2021, while the deepest fall reached 99.94% in 2021.
• A 5-year view of Goodwill & Intangibles shows it stood at $55.2 million in 2020, then declined by 8.4% to $50.6 million in 2021, then sank by 96.86% to $1.6 million in 2022, then plunged by 71.81% to $447591.0 in 2023, then plunged by 71.37% to $128149.6 in 2024.
• The last three Goodwill & Intangibles figures came in at $128149.6 (Q2 2024), $447591.0 (Q4 2023), and $983298.7 (Q2 2023), per Business Quant data.

Peer Comparison